NEW YORK (GenomeWeb News) — Thermo Fisher Scientific today said third-quarter revenues increased over 230 percent as R&D spending rose 52 percent and profit increased more than 300 percent.
 
The company also hinted that the “highly fragmented” market in which it plays “presents opportunities” to make additional acquisitions.
 
Thermo Fisher stressed that last year's results reflect Thermo Electron's operations before its merger with Fisher Scientific last November.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.